The genetic technologies company, Genetic Technologies Limited, has announced a $2 million registered direct offering, involving the sale of 1,000,000 American Depositary Shares (ADSs) at a purchase price of $2.00 per ADS. Additionally, the company will issue unregistered warrants to purchase up to 1,000,000 ADSs. The offering aims to drive revenue, support sales and marketing initiatives, expand into new markets, fund research and development, and cover general corporate purposes. The transaction is expected to close on April 22, 2024. For more information, visit Genetic Technologies Limited’s website.
Genetic Technologies Announces $2 Million Offering for Expansion and Product Development, Australia
Date:
Updated: [falahcoin_post_modified_date]
More like thisRelated
Revolutionary Small Business Exchange Network Connects Sellers and Buyers
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.
District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.
Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.
Baltimore Orioles Host First-Ever ‘Faith Night’ with Players Sharing Testimonies, US
Experience the powerful testimonies of Baltimore Orioles players on their first-ever 'Faith Night.' Hear how their faith impacts their lives on and off the field.
